Vertex - Latest News and Information
Technology Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
VRTX
Vertex is a global biopharmaceutical company focused on discovering, developing, and commercializing transformative medicines for people with serious diseases. The company emphasizes scientific innovation across its research and development efforts, with a geographically diverse footprint including the United States and global operations. Its portfolio includes therapies for conditions such as cystic fibrosis and other serious illnesses, underscoring a commitment to advancing patient care through biology-driven medicine.
Top 5 Stem Cell Good News Stories of 2025
Thermo Fisher, Charles River Workforce Cuts; WuXi Signs Contract with Vertex
Red Hat Solutions for the Hybrid SAP Landscape
Stocks Making the Biggest Moves Midday: Moderna, Instacart, Rivian Automotive, DraftKings, Coinbase & More
The Top 10 PharmTech Videos of 2025
JPMorgan’s 5-Day Office Rule Faces Tepid Pushback as Employee Petition Gains Support
Lilly Strikes Again, Buying CAR-T Firm Orna for $2.4bn
Subba Rao Joins Vertex Group as Co-Founder & Chief Growth Officer
STAT+: Vertex’s CRISPR Treatment for Sickle Cell Disease Hits Unexpected Roadblock
Why Leaders Matter for a Strong Organisational Culture
The Next Wave of Biotech Growth — a Perspective
Corcoran Group Signs 15K-SF Lease at 381 Park Avenue South
Hong Kong's RedotPay Raises $100 Million Series B to Push Global Stablecoin Payments
Top 10 Most Popular Drug Hunter Case Studies of 2025
Eight of the Biggest Immunology and Inflammation (I&I) Deals in 2025
Girija Kolagada Is Country Manager-India and VP-HRBP for APAC, Progress Software
Women in STEM: Unique Impacts in Rare Disease Development
Grading My 25 Stem Cell & Regenerative Medicine Predictions for 2025
Top 10 Most Popular Drug Hunter Resources of 2025
2025 Novel Small Molecule FDA Drug Approvals
